Molbio Diagnostics IPO Listing Price & Gain
Listing price
₹980
Listing gain
+21.44%
Issue price
₹807
Listed on
17 Aug 2026
Grey Market Premium (GMP) is unofficial, unregulated market data reported for information only. It is not a prediction of listing price or gains, and not investment advice.
Frequently asked questions
What was Molbio Diagnostics IPO's listing price?
Molbio Diagnostics listed at ₹980, a +21.44% premium to the ₹807 issue price, on 17 Aug 2026.
When did Molbio Diagnostics IPO list?
Molbio Diagnostics IPO listed on 17 Aug 2026.
Is listing gain a prediction of future returns?
No. Listing gain is simply the difference between the listing price and the issue price on listing day — a reported past fact, not a forecast or investment advice.